Compare Novavax Inc (NVAX) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Taskus Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Taskus Inc trades at $5.86 (market cap $532.07M). The key difference: Novavax Inc is far larger — about 2.4× Taskus Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Taskus Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | TASK | |
|---|---|---|
Market Cap | $1.30B | $532.07M |
Sector | Health | Technology |
52-Week High | $11.19 | $18.21 |
52-Week Low | $6.22 | $4.57 |
Enterprise Value | $800.50M | $927.77M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
